Treatment
NOS guidelines recommend a treatment loading dose of 300,000 IU for treatment of vitamin D deficiency.1 InVita D3 50,000 IU is given as a weekly dose over 6 weeks for the treatment of vitamin D deficiency and is suitable for adults. InVita D3 25,000 IU is suitable for treatment in children (soft capsules can be used in children from 10 years old, oral solution can be used from birth) and is taken once every 2 weeks for 6 weeks
Prevention
A prevention dose of vitamin D3 is recommended in groups who may be at risk from vitamin D deficiency. These include:
- Older patients (particularly in case of falls or fractures) or those who may be institutionalised on hospitalised
- Dark skinned individuals
50,000 IU soft gel capsules and oral solution
The simplicity of a UK guideline-aligned treatment course delivered in just 6 weekly doses 1,2,3
25,000 IU soft gel capsules and oral solution
A licensed vitamin D3 preparation suitable for patients of all ages 4,5
Licensed for the weekly prophylaxis and treatment of vitamin D deficiency in adults and children over 12 years old 6
Licensed for the prophylaxis and treatment of vitamin D deficiency in adults and children over 12 years old 7
A licensed treatment for the prophylaxis of vitamin D deficiency in adults, children, adolescents and pregnant or breast feeding women who have an identified risk.9
A licensed solution for use in pregnancy, breastfeeding and paediatrics aged 0-18 years 8
References:
- National Osteoporosis Society. Vitamin D and Bone Health: A Practical Clinical Guideline for Patient Management. April 2013. https://nos.org.uk/document.doc?id=1352. Accessed August 2018.
- Consilient Health Ltd. InVita D3 50,000 IU oral solution Summary of Product Characteristics.
- Consilient Health Ltd. InVita D3 50,000 IU soft capsules Summary of Product Characteristics.
- Consilient Health Ltd. InVita D3 25,000 IU oral solution Summary of Product Characteristics.
- Consilient Health Ltd. InVita D3 25,000 IU soft capsules Summary of Product Characteristics.
- Consilient Health Ltd. InVita D3 5,600 IU soft capsules Summary of Product Characteristics.
- Consilient Health Ltd. InVita D3 800 IU soft capsules Summary of Product Characteristics.
- Consilient Health Ltd. InVita D3 2,400 IU oral drops. Summary of Product Characteristics.
- Consilient Health Ltd. InVita D3 400 IU soft capsules Summary of Product Characteristics.
Reporting of side effects:
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/. Adverse events should also be reported to Consilient Health (UK) Ltd, Ground Floor, No. 1 Church Road, Richmond upon Thames, Surrey TW9 2QE UK or drugsafety@consilienthealth.com.
This website is developed and funded by Consilient Health Ltd.
Copyright © 2018 Consilient Health. All rights reserved. Web agency GlobalizeMe.
UK/INV/0618/0127(1) Date of preparation: October 2018